GGrantIndex
← Search

Preclinical Efficacy and Intermediate Endpoint Biomarkers - Orientation Meeting

$4,144N01FY2012CANIH

Sri International, Menlo Park CA

Investigators

Abstract

SRI International has been awarded as a prime contractor of RFP-N01-CN25002-78 entitled ¿Preclinical Efficacy and Intermediate Endpoint Biomarkers.¿ They are scheduled to attend the orientation meeting that is scheduled on October 22, 2012.

View original record on NIH RePORTER →